
What is a Botanical Drug?
A botanical drug is made of a single plant or mix of plants. FDA considers the entire mixture as the active pharmaceutical ingredient (API) for a botanical drug.
Developing herbal medicines with known safety and efficacy to prescription botanical drugs in the US is an efficient drug development pathway, comparing to the pathway of purifying a single molecular from a plant.
about the
American Botanical Drug Association
Why We Exist?
The FDA “Botanical Drug Development Guidance for Industry" opens doors for botanical products like herbal medicines and cannabis-derived products to develop into prescription drugs. Developing already-known safe and effective herbal medicines through the FDA botanical drug IND process is an efficient drug development pathway ...

Our Focus
Modern herbal medicines come in formats of pills or capsules. Their safety and efficacy have been demonstrated by daily use on a large population. Identifying already known safe and effective herbal medicines with the potential to be developed as US prescription botanical drugs is an efficient drug development pathway...

Registration open
in
Jan 2023
LEADERSHIP
.jpg)
David Allen
President
.jpg)
Purdeep Gupta
SVP, R&D

Andre Boulet
SVP, Canada

Pai-Ping Fan
SVP, United Kingdom

Simon Tang
General Counsel

Goran Olsson
CFO

Francis Hadji-Minaglou
SVP, France

Mary Brown
SVP, China

Steve Council
SVP, Strategic Initiatives
.jpg)
Chun-Su, Yuan
SVP, Scientific Affairs

Joerg Gruenwald
SVP, Germany

Tirunagari Sreedhar
VP, India Central

John Tobin
SVP, Global BD

Donal Brown
SVP, Manufacturing & Quality

Alex Semprini
SVP, New Zealand

Bassvaraj Nanjwade
VP, India South
International Fund for Botanical Drugs

The International Fund for Botanical Drugs (IFBD) is an nonprofit venture capital philanthropy established as a platform to collectively advancing the research and development of botanical medicines. On this platform, institutions and individuals can participate in the advancement of disease treatment using herbal medicines through contributing to the Fund. Contributors can choosing specific products or disease areas of their interest.
How We Do It?
The ABDA has a pipeline of medicinal herbal formulations ready for clinical trials. Beyond its existing pipeline of botanical drug candidates, ABDA has research partnerships aimed at further identifying herbal formulations for clinical development globally.
Through IFBD, donators can advance the research and development of herbal medicines to treat many challenging medical conditions that are lacking effective chemical drugs. Through IFBD, donators' investment is de-risked.
